Sigma-1R | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

832 results for “Sigma-1R”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Sigma CR150 Versus Sigma CR Knee RCT

191 participants · First posted Aug 17, 2011

In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule

100 participants · First posted Sep 27, 2016

To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients

100 participants · First posted Jul 13, 2020

PFC Sigma Fixed and Mobile Knee Study

754 participants · First posted Sep 21, 2005

Efficacy of Oocyte Activation With Two Types of Ca2+ Ionophore.

44 participants · First posted Oct 30, 2023

GLP-1R Agonist Treatment for Opioid Use Disorder

200 participants · First posted Aug 12, 2024

GLP-1R Actions on Muscle and the Skeleton

50 participants · First posted Sep 4, 2025

A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period

417 participants · First posted Aug 3, 2012

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

365 participants · First posted Mar 31, 2022

DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists

411 participants · First posted Apr 11, 2012

Page 1 of 43